Incidence of Dermatomyositis in a Nationwide Cohort Study of US Veterans

JAMA Dermatol. 2022 Nov 1;158(11):1321-1323. doi: 10.1001/jamadermatol.2022.3112.

Authors

Caitlin M Bolender¹, Amber Jimenez², Jennie T Clarke¹, Tina M Willson^{3

4}, Vanessa W Stevens^{3

4}, Jamie L W Rhoads^{1

3}

Affiliations

¹ Department of Dermatology, University of Utah School of Medicine, Salt Lake City.
² University of Utah School of Medicine, Salt Lake City.
³ Informatics, Decision-Enhancement and Analytic Sciences (IDEAS) Center of Innovation, Veterans Affairs Salt Lake City Health Care System, Salt Lake City, Utah.
⁴ Division of Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City.

No abstract available

Plain language summary

This cohort study evaluates the incidence of dermatomyositis and its trend over time in the US Department of Veterans Affairs health care system.

MeSH terms

Cohort Studies
Dermatomyositis* / diagnosis
Dermatomyositis* / epidemiology
Hospitals, Veterans
Humans
Incidence
United States / epidemiology
United States Department of Veterans Affairs
Veterans*